Parabilis Medicines
Develops medicines targeting historically undruggable protein targets in cancer
$305MSeries F
Role not disclosedHH
HBM Healthcare
Activity from announced rounds
Activity in this selectionUnited States
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $305M 1 disclosed · full round size, not this investor’s share